By Daniel Molina
Sep 16, 2024
The Delta-8 THC battle in Texas continues, with the arena now moving to the Texas Supreme Court. On August 21, 2024, the Texas Department of State Health Services filed an opening brief with the Texas Supreme Court in the case Texas Department of State Health Services v. Sky Marketing Corp. as part of an ongoing effort to ban D8 in Texas, a battle the agency has been waging since 2021.
By Daniel Molina, Jason Adelstone
Sep 12, 2024
In August 2024, nine Texas vape shops were shut down after allegedly selling products over the legal THC limit set by state and federal law. Various interpretations of the 2018 Farm Bill and whether cannabinoids such as Delta-8 and THCA qualify as hemp have left a gray area in the legality of hemp-based products. This Insights post explores the THC thresholds of the products seized during the Texas raid and the DEA’s unclear position on synthetic THC and the definition of hemp.
By Jason Adelstone
Sep 9, 2024
The DEA Hearing on Proposed Rulemaking for cannabis rescheduling will take place on December 2, 2024. What happens next? Read this insights article to learn about the importance of "interested persons" and the administrative law judge appointed to oversee the hearing, the anticipated timeline, the potential impact of the presidential election, and more.
By Jerrico Perez
Sep 6, 2024
If you’re interested in entering the upcoming Delaware adult-use cannabis market, time is running out to apply! Prospective adult-use cultivators, manufacturers, retailers, and testing facilities have until September 30,2024 to submit license applications.
By Chelsie Spencer
Sep 3, 2024
A strong trademark is crucial for cannabis businesses to stand out and thrive. This Insights post explores the importance of trademark protection and breaks down the different categories of trademark distinctiveness, from generic to fanciful. By understanding these categories, entrepreneurs can make informed decisions to safeguard and protect their brand identity.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.